Homepage
amfAR, The Foundation for AIDS Research, is dedicated to ending the global AIDS epidemic through innovative research.
COVID-19, Pregnancy, and Protection
Researchers discover immune mechanisms that protect fetuses of SARS-CoV-2-infected mothers from COVID-19’s ill effects.
amfAR Decries Congress’s Failure to Reauthorize PEPFAR
Immediate action is needed to fund the most successful global health program ever and save lives.
Accelerating Hepatitis B Vaccination
A rapid vaccine schedule could help individuals at risk in the Asia-Pacific region.
Innovations
COVER STORY
Sharon Lewin: On the Leading Edge of Cure Research
Published biannually, Innovations provides updates on amfAR’s research, prevention, education, and policy initiatives; reports from amfAR-sponsored conferences and symposia; overviews of major HIV/AIDS-related issues; and highlights from recent fundraising events.
Read the latest issue.
amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy. Since 1985, amfAR has invested more than $635 million in its programs and has awarded more than 3,500 grants to research teams worldwide.
Watch: Leading the Way to a Cure
Research Grants
amfAR utilizes formal requests for proposals to solicit grant applications for both targeted and general HIV/AIDS research. Proposals are then peer reviewed by the Scientific Advisory Committee on the basis of their relevance, scientific merit, and promise. To date, amfAR has awarded more than 3,500 grants to research teams worldwide.
Requests for Proposals and
General Grant Information
Requests for Proposals and
General Grant Information
Donate to amfAR: Fuel Lifesaving Research
Make your contribution today and join the fight to #CureAIDS. Your support contributes to the advancement of amfAR’s cutting-edge HIV/AIDS research.
Show the world that a cure isn’t just possible—it’s within reach.
Stay Informed
Join our community of supporters and sign up today to
receive our monthly e-newsletter Insights and our biannual magazine Innovations.